Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres.

Abstract excerpt

AIMS: Ameloblastoma is a rare odontogenic tumour with an aggressive local behaviour. Mutations in the mitogen-activated protein kinase pathway, namely BRAF V600E mutations, are a common finding. To date, there is no clear correlation between BRAF V600 mutation and clinical outcome. METHODS: We retrospectively reviewed the medical records of patients who underwent surgery for ameloblastoma between May 1998 and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ameloblastoma
• Share to Bone and Dental Protein Studies